In conclusion, the N-SMase/ceramide pathway is an important target of novel chemotherapy agents for the treatment of glioma.Our previous paper demonstrated that CAPE activated p38 MAPK and that p38 kinase formed a complex with p53, resulting in the release of cytochrome C after treatment with CAPE for 0.5 h. The gene discussed is SMPD2; the disease is glioma.